BACKGROUND: Knowledge about their past medical history is central for childhood cancer survivors to ensure informed decisions in their health management. Knowledge about information provision and information needs in this population is still scarce. We thus aimed to assess: (1) the information survivors reported to have received on disease, treatment, follow-up, and late effects; (2) their information needs in these four domains and the format in which they would like it provided; (3) the association with psychological distress and quality of life (QoL). PROCEDURE: As part of the Follow-up survey of the Swiss Childhood Cancer Survivor Study, we sent a questionnaire to all survivors (≥18 years) who previously participated to the baseline survey, were diagnosed with cancer after 1990 at an age of <16 years. RESULTS: Most survivors had received oral information only (on illness: oral: 82%, written: 38%, treatment: oral: 79%, written: 36%; follow-up: oral: 77%, written: 23%; late effects: oral: 68%, written: 14%). Most survivors who had not previously received any information rated it as important, especially information on late effects (71%). A large proportion of survivors reported current information needs and would like to receive personalized information especially on late effects (44%). Survivors with higher information needs reported higher psychological distress and lower QoL. CONCLUSIONS: Survivors want to be more informed especially on possible late effects, and want to receive personalized information. Improving information provision, both qualitatively and quantitatively, will allow survivors to have better control of their health and to become better decision makers.
BACKGROUND: Knowledge about their past medical history is central for childhood cancer survivors to ensure informed decisions in their health management. Knowledge about information provision and information needs in this population is still scarce. We thus aimed to assess: (1) the information survivors reported to have received on disease, treatment, follow-up, and late effects; (2) their information needs in these four domains and the format in which they would like it provided; (3) the association with psychological distress and quality of life (QoL). PROCEDURE: As part of the Follow-up survey of the Swiss Childhood Cancer Survivor Study, we sent a questionnaire to all survivors (≥18 years) who previously participated to the baseline survey, were diagnosed with cancer after 1990 at an age of <16 years. RESULTS: Most survivors had received oral information only (on illness: oral: 82%, written: 38%, treatment: oral: 79%, written: 36%; follow-up: oral: 77%, written: 23%; late effects: oral: 68%, written: 14%). Most survivors who had not previously received any information rated it as important, especially information on late effects (71%). A large proportion of survivors reported current information needs and would like to receive personalized information especially on late effects (44%). Survivors with higher information needs reported higher psychological distress and lower QoL. CONCLUSIONS: Survivors want to be more informed especially on possible late effects, and want to receive personalized information. Improving information provision, both qualitatively and quantitatively, will allow survivors to have better control of their health and to become better decision makers.
Authors: G Michel; N X von der Weid; M Zwahlen; S Redmond; M-P F Strippoli; C E Kuehni Journal: Pediatr Blood Cancer Date: 2008-01 Impact factor: 3.167
Authors: Claire E Wakefield; Phyllis Butow; Catharine A K Fleming; Gunar Daniel; Richard J Cohn Journal: Pediatr Blood Cancer Date: 2011-09-09 Impact factor: 3.167
Authors: Claudia E Kuehni; Marie-Pierre F Strippoli; Corina S Rueegg; Cornelia E Rebholz; Eva Bergstraesser; Michael Grotzer; Nicolas X von der Weid; Gisela Michel Journal: Cancer Date: 2011-08-05 Impact factor: 6.860
Authors: Theresa H M Keegan; Daphne Y Lichtensztajn; Ikuko Kato; Erin E Kent; Xiao-Cheng Wu; Michelle M West; Ann S Hamilton; Brad Zebrack; Keith M Bellizzi; Ashley W Smith Journal: J Cancer Surviv Date: 2012-03-29 Impact factor: 4.442
Authors: Kim Agnes Helma Nicolaije; Olga Husson; Nicole Paulina Maria Ezendam; Maria Caroline Vos; Rutgerus Franciscus Petrus Maria Kruitwagen; Marnix Lodewijk Maria Lybeert; Lonneke Veronique van de Poll-Franse Journal: Patient Educ Couns Date: 2012-06-01
Authors: Sebastiaan L Knijnenburg; Leontien C Kremer; Cor van den Bos; Katja I Braam; Monique W M Jaspers Journal: Pediatr Blood Cancer Date: 2010-01 Impact factor: 3.167
Authors: Simone Oerlemans; Olga Husson; Floortje Mols; Philip Poortmans; Henk Roerdink; Laurien A Daniels; Carien L Creutzberg; Lonneke V van de Poll-Franse Journal: Ann Hematol Date: 2012-05-26 Impact factor: 3.673
Authors: Gisela Michel; Renée L Mulder; Helena J H van der Pal; Roderick Skinner; Edit Bárdi; Morven C Brown; Janine Vetsch; Eva Frey; Rachael Windsor; Leontien C M Kremer; Gill Levitt Journal: J Cancer Surviv Date: 2019-08-08 Impact factor: 4.442
Authors: Melinda R Stolley; Lisa K Sharp; Christy C Tangney; Linda A Schiffer; Claudia Arroyo; Yoonsang Kim; Richard T Campbell; Mary Lou Schmidt; Kathleen Breen; Karen E Kinahan; Kim J Dilley; Tara O Henderson; Allen D Korenblit; Katya Seligman Journal: Cancer Date: 2015-01-06 Impact factor: 6.860
Authors: Kimberly A Miller; Cynthia N Ramirez; Katherine Y Wojcik; Anamara Ritt-Olson; Lourdes Baezconde-Garbanati; Stefanie M Thomas; David R Freyer; Ann S Hamilton; Joel E Milam Journal: Support Care Cancer Date: 2017-11-09 Impact factor: 3.603
Authors: Anneli V Mellblom; Live Korsvold; Arnstein Finset; Jon Loge; Ellen Ruud; Hanne C Lie Journal: J Adolesc Young Adult Oncol Date: 2015-12 Impact factor: 2.223
Authors: Beeshman S Nandakumar; Joanna E Fardell; Claire E Wakefield; Christina Signorelli; Jordana K McLoone; Jane Skeen; Ann M Maguire; Richard J Cohn Journal: Support Care Cancer Date: 2018-03-02 Impact factor: 3.603
Authors: K Reynolds; M Spavor; Y Brandelli; C Kwok; Y Li; M Disciglio; L E Carlson; F Schulte; R Anderson; P Grundy; J Giese-Davis Journal: J Cancer Surviv Date: 2019-06-27 Impact factor: 4.442
Authors: Melanie R Keats; Kelsey Shea; Louise Parker; Samuel A Stewart; Annette Flanders; Mark Bernstein Journal: J Cancer Educ Date: 2019-08 Impact factor: 2.037